Keryx Biopharma (KERX) Tops Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts KERX Hot Sheet
Price: $3.36 --0%
Financial Fact:
Total research and development: 8.67M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Total research and development: 8.67M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Keryx Biopharma (NASDAQ: KERX) reported Q1 EPS of ($0.28), $0.02 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $1.2 million versus the consensus estimate of $2.45 million.
For earnings history and earnings-related data on Keryx Biopharma (KERX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- OMNIQ Corp. posts Q2 2026 revenue of $7.4M, widens net loss
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
